ArticleJournal of medicinal chemistry2024
Development of a Potent and Selective G2A (GPR132) Agonist.
Victor Hernandez-Olmos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleJournal of medicinal chemistry2024
Victor Hernandez-Olmos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.